Patents for genetic inventions: A tool to promote technological advance or a limitation for upstream inventions?

Technovation

Volumn 25, Issue 12, 2005, Pages 1410-1417

  Thumm, Nikolaus ^a,b,c  

^a Swiss Federal Institute of Intellectual Property   (Switzerland)

^b United Nations Advisory Group   (Switzerland)

^c OECD ^*  (Switzerland)

Author keywords

Access to research; Genetic inventions; Limitation of patent protection; Patenting; Research exemption

Indexed keywords

ACCESS TO RESEARCH; ECONOMIC PROGRESS; GENETIC INVENTIONS; LIMITATION OF PATENT PROTECTION; PATENTING; RESEARCH EXEMPTION;

BIOTECHNOLOGY; DNA; ENGINEERING RESEARCH; GENETIC ENGINEERING; TECHNOLOGY TRANSFER;

PATENTS AND INVENTIONS;

EID: 26444534365     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.technovation.2004.07.009     Document Type: Article

References (15)

1. M. Cho, S. llangasekare, M. Weaver, D. Leonard, and J. Merz Effects of patents and licenses on the provision of clinical genetic testing services Journal of Molecular Diagnostics 5 1 2003 3 8
2. W. Cohen, A. Goto, A. Nagata, R. Nelson, and J. Walsh R&D spillovers, patents and the incentives to innovate in Japan and the United States Research Policy 31 2002 1349 1367
3. A. Deardorff Welfare effects of global patent protection Economica 59 1992 35 51
4. European Commission, 2002. An assessment of the implications fro basic engineering research of failure to publish, or late publication of, papers on subjects which could be patentable under Article 16(b) of directive 98/44/EC on the legal protection of biotechnological inventions [SEC(2002) 50].
5. Galama, J., 2000. Expert opinion on the case for and against the introduction of a grace period into European patent law. Submitted on request of the European Patent Organisation.
6. B. Hall, and R. Ziedonis The patent paradox revisited: an empirical study of patenting in the US semiconductor industry, 1979-1995 RAND Journal of Economics 32 1 2001 101 128
7. M. Heller, and R. Eisenberg Can patents deter innovation? The anti-commons in biomedical research Science 280 1998 698 701
8. OECD Genetic Inventions, Intellectual Property Rights and Licensing Practices, Evidence and Policies 2002
9. OECD Preliminary Results of OECD/BIAC Survey on the Use and Perception of Patents in the Business Community 2003
10. F.M. Scherer, and D. (Hrsg.) Ross Industrial Market Structure and Economic Performance, Dallas, Geneva 3rd ed. 1990
11. Straus, J., 2002. Empirical Survey on Genetic Inventions and Patent Law presented at the OECD expert workshop Genetic Inventions, IPR and Licensing Practices in Berlin.
12. N. Thumm Intellectual Property Rights. National Systems and Harmonisation in Europe 2000 Springer New York
13. N. Thumm Europe's construction of a patent system for biotechnological inventions: an assessment of industry views Technological Forecasting and Social Change 69 2002 917 928
14. Swiss Federal Institute of Intellectual Property (ed.) Research and Patenting in Biotechnology; A Survey in Switzerland 2003 (http://www.ige.ch/E/ jurinfo/j100.htm#2 )
15. Walsh, J., Arora, A., Cohen, W., 2003. Effects of Research Tool Patents and Licensing on Biomedical Innovation. Paper presented at the OECD Conference on IPR, Innovation and Economic Performance, Paris, August.